Tag: Seattle Genetics acquisition of Cascadian Therapeutics
Seattle Genetics to acquire Cascadian Therapeutics to boost oncology portfolio
Pharma acquisition news : Seattle Genetics has made a deal of about $614 million to acquire Cascadian Therapeutics, a California-based biotechnology company focused on the ... Read More